Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared on X:
“The thoracic surgery, medical, and radiation oncology team at MD Anderson presents their outcomes at ASTRO25 for the 21% of patients with LA-NSCLC started on a neoadjuvant chemoICI approach who ended up getting radiation therapy instead of surgery.”
More posts featuring Drew Moghanaki.